InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,001.35
(
0.10%
)
US TECH 100
20,552.40
(
-0.06%
)
Dow Jones
44,293.13
(
0.69%
)
Brent Oil
71.83
(
-2.54%
)
Bitcoin
87,935.14
(
9.26%
)
Post# of 16650
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jlane3965

Send PM Follow Ignore
Followers 3
Posts 337
Boards Moderated 0
Alias Born 05/06/2020

Jlane3965

Re: None

Wednesday, 03/10/2021 7:58:47 AM

Wednesday, March 10, 2021 7:58:47 AM

Post# of 16650
"In addition to supplying hospitals and pharmacies, Tilray is a proud partner with several leading research institutions, including the Murdoch Children's Research Institute in Australia, studying the effectiveness of Tilray medical cannabis as a treatment for pediatric patients with Intellectual Disabilities suffering from Severe Behavioral Problems; a clinical trial in partnership with The Government of New South Wales and University of Sydney Chris O'Brien Lifehouse to develop a novel treatment for chemotherapy-induced nausea, and a study led by the University of Sydney examining the effects of driving under the influence of cannabis."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up